Farther Finance Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$65.9K Sell
1,172
-237
-17% -$10.7K ﹤0.01% 3189
2026
Q2
$39.5K Sell
1,409
-596
-30% -$16.8K ﹤0.01% 3440
2026
Q1
$56.8K Sell
2,005
-741
-27% -$25.3K ﹤0.01% 2906
2025
Q4
$109K Buy
2,746
+1,614
+143% +$59.2K ﹤0.01% 2298
2025
Q3
$39.9K Buy
1,132
+1,073
+1,819% +$37K ﹤0.01% 2579
2025
Q2
$1.93K Buy
59
+8
+16% +$260 ﹤0.01% 3709
2025
Q1
$1.7K Hold
51
– – ﹤0.01% 3453
2024
Q4
$1.56K Sell
51
-5
-9% -$161 ﹤0.01% 3098
2024
Q3
$1.57K Buy
56
+31
+124% +$764 ﹤0.01% 3083
2024
Q2
$563 Hold
25
– – ﹤0.01% 3247
2024
Q1
$727 Sell
25
-79
-76% -$2.65K ﹤0.01% 2898
2023
Q4
$3.71K Buy
+104
New +$3.87K ﹤0.01% 2116

Other funds holding ATRC

Farther Finance Advisors's ATRC Position: Q3 2026 in Review

Farther Finance Advisors reduced its AtriCure (ATRC) stake by 17% in Q3 2026, selling an estimated $10.7K and leaving 1,172 shares worth $65.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3189.

Farther Finance Advisors first reported a position in ATRC in Q4 2023 and has held it in 12 quarters since. The position peaked at $109K in Q4 2025. 6 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

  • Farther Finance Advisors held 1,172 shares of AtriCure worth $65.9K as of Q3 2026.
  • Farther Finance Advisors sold 237 AtriCure shares in Q3 2026, an estimated $10.7K.
  • AtriCure made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3189 holding.
  • Farther Finance Advisors first reported a position in AtriCure in Q4 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's AtriCure position peaked at $109K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.